GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Poly Pharm Co Ltd (SZSE:300630) » Definitions » Short-Term Debt

Hainan Poly Pharm Co (SZSE:300630) Short-Term Debt : ¥361 Mil (As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Hainan Poly Pharm Co Short-Term Debt?

Hainan Poly Pharm Co's Short-Term Debt for the quarter that ended in Sep. 2023 was ¥361 Mil.

Hainan Poly Pharm Co's quarterly Short-Term Debt declined from Mar. 2023 (¥485 Mil) to Jun. 2023 (¥321 Mil) but then increased from Jun. 2023 (¥321 Mil) to Sep. 2023 (¥361 Mil).

Hainan Poly Pharm Co's annual Short-Term Debt increased from Dec. 2020 (¥170 Mil) to Dec. 2021 (¥347 Mil) and increased from Dec. 2021 (¥347 Mil) to Dec. 2022 (¥613 Mil).


Hainan Poly Pharm Co Short-Term Debt Historical Data

The historical data trend for Hainan Poly Pharm Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Poly Pharm Co Short-Term Debt Chart

Hainan Poly Pharm Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.00 250.59 169.77 347.12 613.39

Hainan Poly Pharm Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 538.29 613.39 484.84 321.09 361.10

Hainan Poly Pharm Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Hainan Poly Pharm Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Hainan Poly Pharm Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Hainan Poly Pharm Co (SZSE:300630) Business Description

Traded in Other Exchanges
N/A
Address
No.1509 Binsheng Road, 10th Floor, Zhejiang Province, Hangzhou, CHN, 310051
Hainan Poly Pharm Co Ltd is a pharmaceutical manufacturer in China. It manufactures injections, oral solid formulations, dry suspension, and other active pharmaceutical ingredients. The products offered by the company include Azithromycin for Injection, Ganciclovir Sodium for Injection. Octreotide Acetate Injection, Trimebutine Maleate tablets, Desloratadine, Trimebutine Maleate, and GANCICLOVIR among others.
Executives
Fan De Zhu Independent director
Xie Hui Fang Supervisors
Pu Jian Executives
Xu Zhao Securities Affairs Representative
Shen Shi Hua Executives
Zhou Mao Directors, Directors, and Executives

Hainan Poly Pharm Co (SZSE:300630) Headlines

No Headlines